Biotech Startups in Texas
6 Biotech companies in Texas that have filed with the SEC.
Aspira Women's Health Inc.
BiotechnologyAspira Women's Health Inc. is a leading bio-analytical women's health company dedicated to the development of innovative diagnostic tools specifically for gynecologic diseases. With a strong focus on enhancing early detection and risk assessment, particularly for ovarian cancer, Aspira aims to address significant challenges in women's health diagnostics.
PanTher Therapeutics, Inc.
BiotechnologyPanTher Therapeutics, Inc. is a clinical-stage oncology company that focuses on revolutionizing cancer treatment through localized therapy. By addressing the inefficiencies of systemic drug delivery, PanTher aims to enhance cancer therapies and minimize side effects for patients.
Pulmotherapeutics Inc
BiotechnologyPulmotherapeutics Inc. is a biopharmaceutical company dedicated to creating innovative therapies for respiratory diseases. It focuses on developing advanced treatments for severe pulmonary conditions, making use of cutting-edge technology.
Founded 2024
REVI LIFE SCIENCES, INC.
BiotechnologyRevi Life Sciences, Inc. is a biotechnology-centric company specializing in innovative solutions that enhance the understanding and modeling of human vascular physiology. Their primary focus is on developing in-vitro models that replicate human vascular systems through engineered micro-environments, facilitating advanced research and development within the life sciences sector.
Founded 2023
Telos Biotech Inc.
BiotechnologyTelos Biotech is a biotechnology startup that develops technologies to enhance the manufacturing of cell therapies. The company, launched by Cambrian Bio in 2022, focuses on addressing telomere shortening during cell expansion to improve the function, longevity, and robustness of therapeutic cells used to treat cancer and age-related diseases.
Trinity Nuclein Series C QP Investors LLC
Other TechnologyTrinity Nuclein Series C QP Investors LLC is an investment entity associated with Trinity Investors, a distinguished private equity firm. This vehicle is primarily aimed at funding Nuclein, a biotechnology innovator dedicated to creating advanced rapid diagnostic testing solutions for infectious diseases.
Founded 2025